Iftikhar Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Iftikhar Ahmed has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Attiya Mustafa
BDS Student Bolan University of Medical &Health Sciences Quetta Pakistan
4 shared publicationsZahid Hussain
Armed Forces Institute of Cardiology/National Institute of Heart Diseases Rawalpindi Pakistan
4 shared publicationsAbdul Manaf
House Officer Bolan Medical Complex Hospital Bolan University of Medical &Health Sciences Quetta Pakistan
2 shared publicationsAsif Nadeem
Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
2 shared publicationsFaiza Alam
Resident Gynecology & Obstetrics Bolan Medical Complex Hospital Bolan University of Medical &Health Sciences Quetta Pakistan
2 shared publicationsNaveed Ahmed
MBBS Student Dera Ghazi Khan Medical College DG Khan Pakistan
2 shared publications
Latest Publications
- Open Access
- 27 January 2024
- Published by Link Medical Institute in Journal of Health and Rehabilitation Research
- Vol. 4 (1) , 279-284
Castle Score Versus J-CTO Score for The Prediction of Technical Success in Chronic Total Occlusion Percutaneous Revascularization
Background: Chronic total occlusions (CTOs) present a significant challenge in percutaneous coronary intervention (PCI). Accurate preprocedural assessment and planning are crucial for the success of these interventions. The J-CTO score has been widely used to predict the success of PCI in CTO cases, but recent developments have introduced the EuroCTO (CASTLE) score, which may offer advantages in complex cases. Objective: This study aimed to compare the predictive accuracy of the EuroCTO (CASTLE) score with the J-CTO score in determining the success of PCI in CTO cases, with a focus on their utility in preprocedural planning and risk assessment. Methods: Conducted at a tertiary cardiac care center in Rawalpindi, Pakistan, this analytical cross-sectional study involved 120 patients undergoing PCI for CTO from January 2023 to November 2023. Inclusion criteria were patients aged 18-80 years requiring PCI for CTO, while patients with acute coronary syndromes, pregnant women, or those refusing consent were excluded. Data on clinical, angiographic, and procedural characteristics were systematically recorded. The EuroCTO (CASTLE) and J-CTO scores were calculated based on established algorithms. Technical success was defined as effective revascularization of the CTO lesion with less than 30% residual stenosis and TIMI grade 3 antegrade flow restoration. Statistical analysis was conducted using SPSS 25. Results: The mean age of the participants was 58.85 ± 11.1 years, with a male predominance (62.5%). Hypertension (67.5%) and hyperlipidemia (78.3%) were common comorbidities. The mean procedural time was 132.42 ± 5.11 minutes, and the mean fluoroscopy time was 41.19 ± 2.41 minutes. The J-CTO and EuroCTO (CASTLE) scores were 2.09 ± 0.70 and 1.91 ± 0.69, respectively. Multivariate logistic regression analysis showed comparable predictive performance between the two scores, with slightly better discriminative ability in complex cases for the EuroCTO (CASTLE) score. Conclusion: Both the EuroCTO (CASTLE) and J-CTO scores effectively predict the success of PCI in CTO cases, with the EuroCTO (CASTLE) score showing potential advantages in more complex scenarios. These scoring systems are valuable tools for clinicians in preprocedural planning and risk assessment, enhancing the decision-making process in CTO interventions.
- 27 January 2024
- Published by Link Medical Institute in Journal of Health and Rehabilitation Research
- Vol. 4 (1) , 279-284
Open AccessCastle Score Versus J-CTO Score for The Prediction of Technical Success in Chronic Total Occlusion Percutaneous Revascularization
Background: Chronic total occlusions (CTOs) present a significant challenge in percutaneous coronary intervention (PCI). Accurate preprocedural assessment and planning are crucial for the success of these interventions. The J-CTO score has been widely used to predict the success of PCI in CTO cases, but recent developments have introduced the EuroCTO (CASTLE) score, which may offer advantages in complex cases. Objective: This study aimed to compare the predictive accuracy of the EuroCTO (CASTLE) score with the J-CTO score in determining the success of PCI in CTO cases, with a focus on their utility in preprocedural planning and risk assessment. Methods: Conducted at a tertiary cardiac care center in Rawalpindi, Pakistan, this analytical cross-sectional study involved 120 patients undergoing PCI for CTO from January 2023 to November 2023. Inclusion criteria were patients aged 18-80 years requiring PCI for CTO, while patients with acute coronary syndromes, pregnant women, or those refusing consent were excluded. Data on clinical, angiographic, and procedural characteristics were systematically recorded. The EuroCTO (CASTLE) and J-CTO scores were calculated based on established algorithms. Technical success was defined as effective revascularization of the CTO lesion with less than 30% residual stenosis and TIMI grade 3 antegrade flow restoration. Statistical analysis was conducted using SPSS 25. Results: The mean age of the participants was 58.85 ± 11.1 years, with a male predominance (62.5%). Hypertension (67.5%) and hyperlipidemia (78.3%) were common comorbidities. The mean procedural time was 132.42 ± 5.11 minutes, and the mean fluoroscopy time was 41.19 ± 2.41 minutes. The J-CTO and EuroCTO (CASTLE) scores were 2.09 ± 0.70 and 1.91 ± 0.69, respectively. Multivariate logistic regression analysis showed comparable predictive performance between the two scores, with slightly better discriminative ability in complex cases for the EuroCTO (CASTLE) score. Conclusion: Both the EuroCTO (CASTLE) and J-CTO scores effectively predict the success of PCI in CTO cases, with the EuroCTO (CASTLE) score showing potential advantages in more complex scenarios. These scoring systems are valuable tools for clinicians in preprocedural planning and risk assessment, enhancing the decision-making process in CTO interventions.
- 19 January 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (7) , 1811-1819
Survival Rates and Patient-Reported Outcomes Support the Use of Custom Cement-Over Megaprosthesis (CCOM) in Complex Revision Lower Limb Arthroplasty
- 19 January 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (7) , 1811-1819
Survival Rates and Patient-Reported Outcomes Support the Use of Custom Cement-Over Megaprosthesis (CCOM) in Complex Revision Lower Limb Arthroplasty
- Open Access
- 16 June 2023
- Published by Lahore Medical and Dental College
- Vol. 17 (6) , 112-114
Frequency of New Onset Atrial Fibrillation in Patients Presenting with ST-Segment Elevation Myocardial Infarction
Aim: To study the magnitude of atrial fibrillation in patients with ST segment elevation myocardial infarction. Study Design: Prospective analytic cross-sectional study. Place and duration of study: Department of Cardiology of a Tertiary Cardiac Care Center of Pakistan from 1st June 2022 to 30th November 2022. Methodology: Two hundred and thirty-six patients were selected through non-probability, consecutive sampling technique. Patients were divided into Group 1 who did not develop AF while group 2 included the new cases of AF during in-hospital stay for STEMI. All patients underwent clinical examinations, echocardiography, angiography and percutaneous coronary intervention. Results: Forty five cases with an average age of 71±14 years developed atrial fibrillation. Female population 25(60%) was at higher risk than male 17(40%). In AF group, 22(53.3%) cases of dyslipidemia, 11(26.1%) cases of chronic renal disease, 4(8.8%) cases of prior myocardial infarction, 14(33.3%) cases of diabetes and a single case (2.2%) of implantable cardiac-defibrillator were observed when compared with the non-AF group. Practical Implication: In-hospital complications are also highly associated with AF which may result in high Incidents of mortality. Conclusion: Aging, comorbidities and inferior wall MI are the independent predictors of AF. In-hospital complications are associated with AF which may result in high incidents of mortality. Early diagnosis of STEMI patients with a high risk of developing AF is necessary to reduce the morbidity and mortality. Keywords: Atrial fibrillation, ST-segment elevation, Myocardial infarction
- 16 June 2023
- Published by Lahore Medical and Dental College
- Vol. 17 (6) , 112-114
Open AccessFrequency of New Onset Atrial Fibrillation in Patients Presenting with ST-Segment Elevation Myocardial Infarction
Aim: To study the magnitude of atrial fibrillation in patients with ST segment elevation myocardial infarction. Study Design: Prospective analytic cross-sectional study. Place and duration of study: Department of Cardiology of a Tertiary Cardiac Care Center of Pakistan from 1st June 2022 to 30th November 2022. Methodology: Two hundred and thirty-six patients were selected through non-probability, consecutive sampling technique. Patients were divided into Group 1 who did not develop AF while group 2 included the new cases of AF during in-hospital stay for STEMI. All patients underwent clinical examinations, echocardiography, angiography and percutaneous coronary intervention. Results: Forty five cases with an average age of 71±14 years developed atrial fibrillation. Female population 25(60%) was at higher risk than male 17(40%). In AF group, 22(53.3%) cases of dyslipidemia, 11(26.1%) cases of chronic renal disease, 4(8.8%) cases of prior myocardial infarction, 14(33.3%) cases of diabetes and a single case (2.2%) of implantable cardiac-defibrillator were observed when compared with the non-AF group. Practical Implication: In-hospital complications are also highly associated with AF which may result in high Incidents of mortality. Conclusion: Aging, comorbidities and inferior wall MI are the independent predictors of AF. In-hospital complications are associated with AF which may result in high incidents of mortality. Early diagnosis of STEMI patients with a high risk of developing AF is necessary to reduce the morbidity and mortality. Keywords: Atrial fibrillation, ST-segment elevation, Myocardial infarction
- Open Access
- 16 June 2023
- Published by Lahore Medical and Dental College
- Vol. 17 (6) , 115-117
Comparison of Contrast Induced Nephropathy in Diabetics and Non-Diabetics after Percutaneous Coronary Intervention in Previously Normal Renal Functions
Aim: To compare the incidence and severity of contrast-induced nephropathy (CIN) in patients who underwent percutaneous coronary intervention at tertiary care hospital of Pakistan. Study design: Prospective analytic cross-sectional study. Place and duration of study: Department of Cardiology of a Tertiary Cardiac Care Center of Pakistan from 1st April 2022 to 30th September 2022. Methodology: Two hundred and fifty patients of coronary artery disease older than 18 years irrespective of gender were enrolled using non-probability consecutive sampling technique. The patients were divided into two groups; diabetic and non-diabetic, who received a contrast medium during the procedure. Results: Thirty seven (14.66%) patients were diagnosed with CIN after percutaneous coronary intervention. Patients with diabetes 25(69%) were more prone to develop CIN compared with non-diabetic patients 12(31%). Also, patients with diabetes have significantly high levels of post procedure creatinine levels compared with the non-diabetic patients. Practical Implication: it is cleared from the body by glomerular filtration. The mechanism of CIN is dependent on the medullary ischemia, oxidative stress and tubular cell toxicity. Conclusion: Contrast-induced nephropathy is a common complication following percutaneous coronary intervention and is more prevalent in diabetic patients. However, none of the patients require hemodialysis. Keywords: Contrast-induced nephropathy, Diabetic, Non-diabetic, Percutaneous coronary intervention, Renal function
- 16 June 2023
- Published by Lahore Medical and Dental College
- Vol. 17 (6) , 115-117
Open AccessComparison of Contrast Induced Nephropathy in Diabetics and Non-Diabetics after Percutaneous Coronary Intervention in Previously Normal Renal Functions
Aim: To compare the incidence and severity of contrast-induced nephropathy (CIN) in patients who underwent percutaneous coronary intervention at tertiary care hospital of Pakistan. Study design: Prospective analytic cross-sectional study. Place and duration of study: Department of Cardiology of a Tertiary Cardiac Care Center of Pakistan from 1st April 2022 to 30th September 2022. Methodology: Two hundred and fifty patients of coronary artery disease older than 18 years irrespective of gender were enrolled using non-probability consecutive sampling technique. The patients were divided into two groups; diabetic and non-diabetic, who received a contrast medium during the procedure. Results: Thirty seven (14.66%) patients were diagnosed with CIN after percutaneous coronary intervention. Patients with diabetes 25(69%) were more prone to develop CIN compared with non-diabetic patients 12(31%). Also, patients with diabetes have significantly high levels of post procedure creatinine levels compared with the non-diabetic patients. Practical Implication: it is cleared from the body by glomerular filtration. The mechanism of CIN is dependent on the medullary ischemia, oxidative stress and tubular cell toxicity. Conclusion: Contrast-induced nephropathy is a common complication following percutaneous coronary intervention and is more prevalent in diabetic patients. However, none of the patients require hemodialysis. Keywords: Contrast-induced nephropathy, Diabetic, Non-diabetic, Percutaneous coronary intervention, Renal function
- Open Access
- 22 November 2022
- Published by Army Medical College in Pakistan Armed Forces Medical Journal
- Vol. 72 (SUPPL-3) , S491-95
Comparision of Myocardial Viability Assessment Between Cardiac Magnetic Resonance Imaging and Single Photon Emission Computed Tomography in Patients with Coronary Artery Disease
Objective: To assess the myocardial viability on cardiac magnetic resonance imaging compared with single photon emission computed tomography scan in patients with coronary artery disease. Study Design: This study was cross sectional study. Place and Duration of Study: Cardiac Magnetic Resonance Imaging and Nuclear Medicine Departments of a Tertiary Cardiac Care Center of Rawalpindi Pakistan, from Dec 2021 to May 2022. Methodology: This study was cross sectional study conducted from December 2021 to May 2022 at Cardiac Magnetic resonance imaging and Nuclear Medicine departments of a Tertiary Cardiac Care Center of Rawalpindi Pakistan. Thirty patients (n=30) with coronary artery disease were selected using non-probability consecutive sampling technique to determine the viable myocardium using cardiac magnetic resonance imaging (CMR) and single photon emission computed tomography (SPECT) scan. Patients with left ventricular dysfunction having ejection fraction equal to or less than forty-five percent and coronary artery disease were included. Results: Using 20 segment models, the mean number of viable segments in SPECT scan and CMR were 16.6±3.18 and 15.47±3.84, respectively while the non-viable segments were 3.4±3.1 and 5.17±4.6, respectively. There was statically little difference in results of Single-photon Emission Computerized Tomography and Cardiac Magnetic Resonance Imaging to determine viable myocardium (pConclusion: Assessment of myocardial viability has keen role in diagnostic and prognostic work up of coronary artery disease patients who are candidates of revascularization. Stunned and hibernating myocardium are two states oreversible myocardial dysfunction.....
- 22 November 2022
- Published by Army Medical College in Pakistan Armed Forces Medical Journal
- Vol. 72 (SUPPL-3) , S491-95
Open AccessComparision of Myocardial Viability Assessment Between Cardiac Magnetic Resonance Imaging and Single Photon Emission Computed Tomography in Patients with Coronary Artery Disease
Objective: To assess the myocardial viability on cardiac magnetic resonance imaging compared with single photon emission computed tomography scan in patients with coronary artery disease. Study Design: This study was cross sectional study. Place and Duration of Study: Cardiac Magnetic Resonance Imaging and Nuclear Medicine Departments of a Tertiary Cardiac Care Center of Rawalpindi Pakistan, from Dec 2021 to May 2022. Methodology: This study was cross sectional study conducted from December 2021 to May 2022 at Cardiac Magnetic resonance imaging and Nuclear Medicine departments of a Tertiary Cardiac Care Center of Rawalpindi Pakistan. Thirty patients (n=30) with coronary artery disease were selected using non-probability consecutive sampling technique to determine the viable myocardium using cardiac magnetic resonance imaging (CMR) and single photon emission computed tomography (SPECT) scan. Patients with left ventricular dysfunction having ejection fraction equal to or less than forty-five percent and coronary artery disease were included. Results: Using 20 segment models, the mean number of viable segments in SPECT scan and CMR were 16.6±3.18 and 15.47±3.84, respectively while the non-viable segments were 3.4±3.1 and 5.17±4.6, respectively. There was statically little difference in results of Single-photon Emission Computerized Tomography and Cardiac Magnetic Resonance Imaging to determine viable myocardium (pConclusion: Assessment of myocardial viability has keen role in diagnostic and prognostic work up of coronary artery disease patients who are candidates of revascularization. Stunned and hibernating myocardium are two states oreversible myocardial dysfunction.....
- Open Access
- 22 November 2022
- Published by Army Medical College in Pakistan Armed Forces Medical Journal
- Vol. 72 (SUPPL-3) , S461-66
Comparison of Left Ventricular Ejection Fraction in Heart Failure Patients on Echocardiography, Cardiac Magnetic Resonance Imaging and Single Photon Emission Computed Tomography
Objective: To compare the left ventricular ejection fraction on echocardiograph, cardiac magnetic resonance imaging and single-photon emission computed tomography scan in heart failure patients. Study Design: This was a prospective cross-sectional study. Place and Duration of Study: Tertiary Cardiac Care Center of Rawalpindi, Pakistan, from Nov 2021 to Apr 2022. Methodology: This was a prospective cross-sectional study conducted from November 2021 to April 2022 at a tertiary cardiac care center of Rawalpindi. Thirty (n=30) heart failure patients of either gender with reduced ejection fraction were selected by consecutive sampling technique and were analyzed to quantify their left ventricular ejection fraction (LVEF) using Echo, CMR and SPECT scan. All three modalities were used to measure LVEF in these patients and were compared accordingly. Results: The LVEF measured by Cardiac Magnetic Resonance Imaging, Single Photon Emission Computed Tomography Scan and Echocardiography was in the range of 15% to 67%. The mean LVEF was 37.2±14.2 by CMR, 37.17±14.1 by SPECT and 38±12.3 by Echo. The mean LVEF determined by SPECT was slightly lower while that determined by Echocardiography was slightly higher. The measured p-value of LVEF by the three modalities, however, indicated statistically difference (p-value <0.05). Conclusion: Although the literature shows diversity in results of these modalities, CMR is considered the standard reference for assessment of LVEF when interpreted by an expert observer. We in our study found that all three modalities are complimentary to each other and can be used interchangeably depending upon the availability of the equipment and reporting expertise of the observers.
- 22 November 2022
- Published by Army Medical College in Pakistan Armed Forces Medical Journal
- Vol. 72 (SUPPL-3) , S461-66
Open AccessComparison of Left Ventricular Ejection Fraction in Heart Failure Patients on Echocardiography, Cardiac Magnetic Resonance Imaging and Single Photon Emission Computed Tomography
Objective: To compare the left ventricular ejection fraction on echocardiograph, cardiac magnetic resonance imaging and single-photon emission computed tomography scan in heart failure patients. Study Design: This was a prospective cross-sectional study. Place and Duration of Study: Tertiary Cardiac Care Center of Rawalpindi, Pakistan, from Nov 2021 to Apr 2022. Methodology: This was a prospective cross-sectional study conducted from November 2021 to April 2022 at a tertiary cardiac care center of Rawalpindi. Thirty (n=30) heart failure patients of either gender with reduced ejection fraction were selected by consecutive sampling technique and were analyzed to quantify their left ventricular ejection fraction (LVEF) using Echo, CMR and SPECT scan. All three modalities were used to measure LVEF in these patients and were compared accordingly. Results: The LVEF measured by Cardiac Magnetic Resonance Imaging, Single Photon Emission Computed Tomography Scan and Echocardiography was in the range of 15% to 67%. The mean LVEF was 37.2±14.2 by CMR, 37.17±14.1 by SPECT and 38±12.3 by Echo. The mean LVEF determined by SPECT was slightly lower while that determined by Echocardiography was slightly higher. The measured p-value of LVEF by the three modalities, however, indicated statistically difference (p-value <0.05). Conclusion: Although the literature shows diversity in results of these modalities, CMR is considered the standard reference for assessment of LVEF when interpreted by an expert observer. We in our study found that all three modalities are complimentary to each other and can be used interchangeably depending upon the availability of the equipment and reporting expertise of the observers.
- Open Access
- 1 November 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 106 (5) , 1446-1451
Tetralogy of Fallot Repair in Developing Countries: International Quality Improvement Collaborative
- 1 November 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 106 (5) , 1446-1451
Open AccessTetralogy of Fallot Repair in Developing Countries: International Quality Improvement Collaborative